Clinical Laserthermia Systems AB (publ) - Asset Resilience Ratio

Latest as of June 2023: 0.31%

Clinical Laserthermia Systems AB (publ) (CLS-B) has an Asset Resilience Ratio of 0.31% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Clinical Laserthermia Systems AB (publ) (CLS-B) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Skr139.00K

≈ $14.96K USD Cash + Short-term Investments

Total Assets

Skr44.47 Million

≈ $4.79 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2022)

This chart shows how Clinical Laserthermia Systems AB (publ)'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see CLS-B current and non-current assets.

Liquid Assets Composition Over Time

This chart breaks down Clinical Laserthermia Systems AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Clinical Laserthermia Systems AB (publ) total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr139.00K	0.31%
Total Liquid Assets	Skr139.00K	0.31%

Asset Resilience Insights

Limited Liquidity: Clinical Laserthermia Systems AB (publ) maintains only 0.31% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Clinical Laserthermia Systems AB (publ) Industry Peers by Asset Resilience Ratio

Compare Clinical Laserthermia Systems AB (publ)'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd SHE:002223	Medical Devices	0.84%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	34.37%
Stratec SE XETRA:SBS	Medical Devices	0.29%
Shinhung KO:004080	Medical Devices	4.17%
DRTECH Corporation KQ:214680	Medical Devices	5.18%
Novacyt PA:ALNOV	Medical Devices	0.02%
Diagnostic Medical Systems SA PA:ALDMS	Medical Devices	1.48%

Annual Asset Resilience Ratio for Clinical Laserthermia Systems AB (publ) (2017–2022)

The table below shows the annual Asset Resilience Ratio data for Clinical Laserthermia Systems AB (publ).

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	0.28%	Skr139.49K ≈ $15.01K	Skr49.51 Million ≈ $5.33 Million	-43.86pp
2021-12-31	44.14%	Skr29.46 Million ≈ $3.17 Million	Skr66.74 Million ≈ $7.18 Million	+18.74pp
2020-12-31	25.40%	Skr11.28 Million ≈ $1.21 Million	Skr44.40 Million ≈ $4.78 Million	+16.07pp
2019-12-31	9.32%	Skr3.60 Million ≈ $387.93K	Skr38.67 Million ≈ $4.16 Million	-31.96pp
2018-12-31	41.28%	Skr23.95 Million ≈ $2.58 Million	Skr58.02 Million ≈ $6.24 Million	+10.97pp
2017-12-31	30.31%	Skr13.62 Million ≈ $1.47 Million	Skr44.94 Million ≈ $4.84 Million	--

pp = percentage points

About Clinical Laserthermia Systems AB (publ)

ST:CLS-B Sweden Medical Devices

Market Cap

$9.40 Million

Skr87.33 Million SEK

Market Cap Rank

#27328 Global

#595 in Sweden

Share Price

Skr1.80

Change (1 day)

-1.42%

52-Week Range

Skr1.80 - Skr10.48

All Time High

Skr1089.26